Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Basant A. Abou-Taleb"'
Publikováno v:
Drug Development and Industrial Pharmacy. 46:192-199
Both physicians and patients in Egypt often express concern as to the clinical efficacy of locally manufactured glimepiride tablet generics whenever adequate control of blood sugar is not a...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9612c5bd933f605b4237661da488aa2
https://doi.org/10.1080/03639045.2020.1716369
https://doi.org/10.1080/03639045.2020.1716369
Publikováno v:
Drug Development and Industrial Pharmacy. 44:1762-1769
Controversies surround levothyroxine sodium as a drug and product, and are reflected in compendia (USP vs BP) differences in levothyroxine sodium tablets specifications concerning potency limit and dissolution test conditions, and in lack of consensu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3cad558cd7c4308906e39c8bbdb8f9
https://doi.org/10.1080/03639045.2018.1496446
https://doi.org/10.1080/03639045.2018.1496446
Autor:
Nawal M. Khalafallah, Mohamed Ismail Nounou, Saleh A.H. Khalil, Maha Bondok, Basant A. Abou-Taleb
Publikováno v:
Annales d'Endocrinologie. 79:23-29
A clinical study was initiated in response to patients' complaints, supported by the treating physicians, of suspected differences in efficacy among multisource levothyroxine sodium tablets marketed in Egypt. The study design was a multiple dose (100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21efbd71bd9f739b55c9ce218c66d7ec
https://doi.org/10.1016/j.ando.2017.10.002
https://doi.org/10.1016/j.ando.2017.10.002